ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2019

TIM-3 in endometrial carcinomas: an immunotherapeutic target expressed by mismatch repair-deficient and intact cancers.

Margaret Moore et al.PubMed ↗Publisher ↗

No numbers read from the abstract.